Skip to main content
Clinical Trials/DRKS00000433
DRKS00000433
Completed
Not Applicable

Transcutaneous should replace arterial PCO2 monitoring during nocturnal noninvasive ventilation

niversitätsklinik FreiburgInnere Medizin V - Pneumologie0 sites24 target enrollmentJune 7, 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
J00-J99
Sponsor
niversitätsklinik FreiburgInnere Medizin V - Pneumologie
Enrollment
24
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 7, 2010
End Date
May 20, 2009
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinik FreiburgInnere Medizin V - Pneumologie

Eligibility Criteria

Inclusion Criteria

  • Cardio\-respiratory stable patients with a pH \>7,30 will be included. Patients will be studied during a clinical check up visit in the sleep unit of the Department of Pneumology, Univeristy Hospital Freiburg. Inclusion criteria are independent from the underlying disease causing ventilatory failure.

Exclusion Criteria

  • Patients with evidence of acute respiratory failure (e.g. worsening symptoms during the last two weeks, a breathing frequency (fb) \> 30/min, a pH \< 7\.35, or signs of respiratory infections) were excluded. In addition, obese patients with an BMI \>35 kg/m2 will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials